Navigation Links
Abbott to Present Data on Several Investigational Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:6/3/2010

RCC), solid tumors, non small cell lung cancer (NSCLC) and selected hematologic malignancies such as leukemia.

PARP Inhibitors (veliparib) – Veliparib is an oral PARP-inhibitor that was discovered and developed by Abbott researchers to prevent DNA repair in cancer cells and increase the effectiveness of common DNA-damaging therapies like chemotherapy or radiation. Veliparib is currently being studied in more than a dozen cancers and tumor types, including Phase II studies in melanoma and breast cancer. Veliparib is also being studied in the I-SPY 2 breast cancer trial, led by the Foundation for the National Institutes of Health.

Bcl-2 Family Protein Inhibitors (navitoclax) – Navitoclax restores apoptosis or programmed cell death, a natural mechanism for the elimination of cancerous cells, by inhibiting the function of Bcl-2 proteins. Bcl-2 regulates apoptosis, as well as tumor formation and tumor growth, and can enable cancer cells to resistance to treatment. Navitoclax is in clinical trials for lymphomas and solid tumors, including small cell lung cancer. Additionally, preclinical data have shown that Bcl-2 family protein inhibitors have the potential to enhance the effects of chemotherapy and radiation used to treat other types of cancer, such as non-small cell lung cancer.

Elotuzumab (HuLuc63) – Elotuzumab is a humanized monoclonal antibody that binds to CS1, a cell-surface glycoprotein that is highly expressed on myeloma cells but minimally expressed on normal human cells. Abbott is developing elotuzumab for multiple myeloma in collaboration with Bristol-Myers Squibb Company.

Beyond pharmaceutical research, Abbott provides supportive care products and diagnostics related to oncology. The company offers a broad range of pharmaceutical and nutritional products to help people living with cancer, inclu
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. Abbotts Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
3. Abbotts Investigational MitraClip(R) System Demonstrates Strong Safety Results and Improved Clinical Outcomes for Common Causes of Leaky Heart Valves
4. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
5. Assegai Wins Big Settlement Against ABBOTTs Subsidiary
6. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
7. Abbott Chairman and CEO Miles D. White to Present at Sanford Bernstein Strategic Decisions Conference
8. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
9. Abbott Completes Acquisition of Facet Biotech
10. Abbott Completes Acquisition of STARLIMS Technologies
11. Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015  Thoratec Corporation (NASDAQ: THOR ), ... support and restore failing hearts, announced today that Marta ... of President, International. This new Europe ... outside of North America , including ... Latin America , and reports directly to ...
(Date:5/1/2015)... 1, 2015 Braeburn Pharmaceuticals announced ... therapeutic focus beyond addiction and pain to ... Braeburn has acquired an implantable, six-month formulation ... for treatment of schizophrenia from Endo Pharmaceuticals. ... rights to other potential applications of the ...
(Date:5/1/2015)... SUNNYVALE, Calif., May 1, 2015 Pharmacyclics, Inc. ... results for the quarter ended March 31, 2015, as ... merger with AbbVie Inc., no conference call will be held. ... the quarter ended March 31, 2015 increased to $206 ... 31, 2014. , Worldwide IMBRUVICA ® (ibrutinib) ...
Breaking Medicine Technology:Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31
... Following is a statement by Linda A. Suydam, D.P.A., president ... of the National Institute on Drug Abuse,s (NIDA,s) Monitoring the ... the Future survey speak to the need for continued efforts ... to talk to their teens about medicine abuse. The Consumer ...
... , DUBLIN, Ohio, Dec. 14 Cardinal Health ... the following events: , Goldman Sachs CEO Unplugged Conference ... Conference Center in New York. 28th Annual J.P. Morgan ... Westin St. Francis Hotel in San Francisco. , At these ...
Cached Medicine Technology:Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2Statement From the Consumer Healthcare Products Association(CHPA) on Annual Monitoring the Future Survey on Drug Abuse 3Cardinal Health Executives to Speak at Two Investor Events in January 2
(Date:5/3/2015)... 03, 2015 Indiana Fiber Network, LLC ... Bank Computer Services, Inc (BCS) has selected IFN as ... states, “The technology, service, and working relationship with IFN ... the local feel you get with IFN. I ... IFN makes local decisions and operates as a local ...
(Date:5/3/2015)... May 03, 2015 Looking for ... will directly impact your career? The Master of ... dynamic leaders in multinational companies and for professionals ... a changing global landscape, differences in culture, religion, ... The EMIB program develops the global competence and ...
(Date:5/3/2015)... SpineFrontier, a Less Exposure Surgery (LES) ... produce and market their new sacroiliac joint fusion screw, ... outpatient settings and is compatible with both lateral and ... been extensively researched and refined by SpineFrontier, the first ... approach in conjunction with a sacroiliac joint fusion system ...
(Date:5/3/2015)... Burnsville MN (PRWEB) May 03, 2015 ... in workplace safety solutions, announces its appearance at the ... Health Conference. Products that HealthPostures will exhibit at the ... Largest of the sit stand solutions is the 6100 ... push button height control, an adjustable keyboard tray, extended ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 Ticket Down has ... for the long awaited event today, Saturday, May 2nd ... Diehard boxing fans will be able to secure tickets for ... The fight that boxing fans have wanted for more than ... ago. Floyd “Money” Mayweather will step inside the ring to ...
Breaking Medicine News(10 mins):Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:Bank Computer Services, Inc Selects Indiana Fiber Network, LLC as Fiber Transport Provider 3Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3
Shiv Sena on Sunday strongly reacted to the recent Union Health Ministry notice to yoga guru Baba Ramdev,// saying the government is compromising national interests in connivance with multinational co...
... Atlas released early December in South Africa confirms that ... India in the pre-diabetic phase (Impaired Glucose Tolerance, IGT). ... that began in 2000, begins with the preamble: "With ... increasing rate, the prevalence of diabetes is predicted to ...
... from the Institute Pasteur has recently shown that the ... host's fat cells. //This formidable pathogen is protected against ... which it may remain dormant for years. ... on possible strategies for fighting tuberculosis. Attempts to eradicate ...
... An enzyme found at elevated levels in several human ... fruit flies//, a discovery that provides a new model ... cancer, according to researchers. ,Using fluorescent staining and ... in a gene called aurora-A to observe how changes ...
... collaborators have found that the genetically engineered bacteria that ... set the stage for a new, biobased method of ... toothpaste, mouthwash and other products. ,Xylitol is ... to some degree by the human body. It is ...
... the Department of Health plans, school girls as young ... disease, which can cause cervical cancer//. Researchers have found ... the key causes of cervical cancer, which kills around ... be immunized against the human papilloma virus (HPV) before ...
Cached Medicine News:Health News:Tuberculosis: The Bacillus Takes Refuge in Adipose Cells 2Health News:Run Amok Enzyme Causes Same Problems in Both Humans and Fruit Flies 2
The opaque outer circle will white-out even the darkest iris, making your pupil the only spot of black in a sea of white....
This lens gives the appearance of mystery and mayhem behind the blackest of eyes....
Soft silicone brush tip allows atraumatic brushing and manipulation of retina surface. Silicone brush extends 3mm beyond end of cannula. Luer lock hub for easy, secure connection to a backflush handl...
Healon vitreous aspirating cannula, 21 gauge....
Medicine Products: